Translatum Medicus

Translatum Medicus is a preclinical drug development company focused on macrophage modulation to treat dry AMD and other blinding eye disease

[Ophthalmology Innovation Source @OISTWEETS]

Translatum Medicus’ Shelley Boyd reports at #OISAAO plans for Ph1/2a, Ph2 trial of TMi-018 for dry AMD. TMi therapies target macrophages responsible for geographic atrophy at the gene-regulation level. Models show TMi-018 can completely block atrophy.

[Translatum Medicus @tmibio]

Congrats #TraceryOphthalmics, @A2APharma and @envisagenics for winning the #Artificialintelligence for Drug Discovery #QuickFireChallenge. Well done! 👍🏻

[BenchSci @BenchSci]

@tmibio on precision medicine for retinal diseases at @JLABS AI in drug discovery #MachineLearning #UofT

[Johnson & Johnson Innovation @JNJInnovation]

The finalists are in! Don't forget to register to watch our 7 finalists pitch for up to $100K in multiple grants on December 12th at #JLABSToronto! #QuickFireChallenge #ArtificialIntelligence #DrugDiscovery https://t.co/Opp9Qdn2Ye

[OBIO @OBIOscience]

OBIO is happy to support Dr. Shelley Boyd’s Saving Sight in an Aging World event hosted by @StMikesHospital Foundation. #healthscience

[Translatum Medicus @tmibio]

Check out "Saving Sight in an Aging World" https://t.co/AJ2TfVBhgV @Eventbrite

[Translatum Medicus @tmibio]

Help prevent #blindness and save sight with Dr. Shelley Boyd, @StMikesHospital & @Rosenberg_Dave
Join us for a fun and informative evening at #JLABSToronto @MaRSDD: https://t.co/aBU4zG8dlW
#Toronto #SavingSight #AMD #MacularDegeneration #research #innovation #medtech

[Translatum Medicus @tmibio]

Genentech's second Phase III study for dry #MacularDegeneration (GA) also fails to meet primary endpoint: https://t.co/54pAqTjhkN
More #research is needed to prevent #blindness
#Ophthalmology #biotech

[Gordon Bethwaite @gordonbethwaite]

Wondering whether #OISAAO is worth attending? Ask the 1000+ people in this room @OISTWEETS

[Translatum Medicus @tmibio]

Help prevent #blindness and save sight with Dr. Shelley Boyd, @StMikesHospital & @Rosenberg_Dave
Join us for a fun and informative evening at #JLABSToronto @MaRSDD: https://t.co/aBU4zG8dlW
#Toronto #SavingSight #AMD #MacularDegeneration #research #innovation #medtech

[Translatum Medicus @tmibio]

Glad to be able to see the healthcare visionaries 5 year anniversary panel at #JLABSCEOSummit @JNJInnovation

[Translatum Medicus @tmibio]

Fireside chat with @melindarichter #JLABSCEOSummit #JLABS @JNJInnovation

[Translatum Medicus @tmibio]

Come check out TMi at poster board 30 #RESIBOS17 #InnovationChallenge

[Translatum Medicus @tmibio]

Genentech's first phase III study for GA fails to meet year 1 endpoint #Ophthalmology #Biotech https://t.co/SwjUl58LbC

[Translatum Medicus @tmibio]

TMi founder Shelley Boyd presenting at #OISASRS today @OISTWEETS

#Ophthalmology #EyeOnInnovation #Biotechnology #DryAMD #Healthcare

[Johnson & Johnson Innovation @JNJInnovation]

We are celebrating #IWD2017 at all our #JLABS sites! #JLABSToronto #JLABSBOS #JLABSBay #JLABSSD #JLABSTMC #BeBoldForChange

[Johnson & Johnson @JNJNews]

#JNJ launches #GenH Challenge at @sxsw to find novel solutions to the world's biggest healthcare challenges. #SXSW

[Johnson & Johnson Innovation @JNJInnovation]

Congratulations to @JanssenGlobal for winning @eyeforpharma “The Most Admired Pharmaceutical Company 2017” #E4PBarca #unitepharma #JNJ

[Translatum Medicus @tmibio]

BBC News - Google's DeepMind to peek at NHS eye scans for disease analysis https://t.co/esXfkD7RzP